Helping to share the web since 1996
Parsatuzumab is a humanized monoclonal antibody designed for the treatment of cancers, especially the solid tumors. It acts as an immunomodulator and binds to EGFL7.
Upgrade OptionsPublished by RecombinantAntibody
News, Reviews & Offers
There are no posts for this page yet.
